DNA methylation profiling distinguishes histological subtypes of renal cell carcinoma

References

• Kovacs G, Akhtar M, Beckwith BJ, Bugert P, Cooper CS, Delahunt B, et al. The Heidelberg classification of renal cell tumours. J Pathol 1997; 183:131 - 3; http://dx.doi.org/10.1002/(SICI)1096-9896(199710)183:2<131::AID-PATH931>3.0.CO;2-G; PMID: 9390023
   PubMed Web of Science ®Google Scholar
• Maher ER. Genetics of familial renal cancers. Nephron Exp Nephrol 2011; 118:e21 - 6; http://dx.doi.org/10.1159/000320892; PMID: 21071978
   PubMedGoogle Scholar
• Linehan WM, Srinivasan R, Schmidt LS. The genetic basis of kidney cancer: a metabolic disease. Nat Rev Urol 2010; 7:277 - 85; http://dx.doi.org/10.1038/nrurol.2010.47; PMID: 20448661
   PubMed Web of Science ®Google Scholar
• Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993; 260:1317 - 20; http://dx.doi.org/10.1126/science.8493574; PMID: 8493574
   PubMed Web of Science ®Google Scholar
• Schmidt L, Duh FM, Chen F, Kishida T, Glenn G, Choyke P, et al. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet 1997; 16:68 - 73; http://dx.doi.org/10.1038/ng0597-68; PMID: 9140397
   PubMed Web of Science ®Google Scholar
• Tomlinson IP, Alam NA, Rowan AJ, Barclay E, Jaeger EE, Kelsell D, et al, Multiple Leiomyoma Consortium. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 2002; 30:406 - 10; http://dx.doi.org/10.1038/ng849; PMID: 11865300
   PubMed Web of Science ®Google Scholar
• Nickerson ML, Warren MB, Toro JR, Matrosova V, Glenn G, Turner ML, et al. Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome. Cancer Cell 2002; 2:157 - 64; http://dx.doi.org/10.1016/S1535-6108(02)00104-6; PMID: 12204536
   PubMed Web of Science ®Google Scholar
• Varela I, Tarpey P, Raine K, Huang D, Ong CK, Stephens P, et al. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature 2011; 469:539 - 42; http://dx.doi.org/10.1038/nature09639; PMID: 21248752
   PubMed Web of Science ®Google Scholar
• Dalgliesh GL, Furge K, Greenman C, Chen L, Bignell G, Butler A, et al. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature 2010; 463:360 - 3; http://dx.doi.org/10.1038/nature08672; PMID: 20054297
   PubMed Web of Science ®Google Scholar
• van Haaften G, Dalgliesh GL, Davies H, Chen L, Bignell G, Greenman C, et al. Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nat Genet 2009; 41:521 - 3; http://dx.doi.org/10.1038/ng.349; PMID: 19330029
   PubMed Web of Science ®Google Scholar
• Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 2000; 25:315 - 9; http://dx.doi.org/10.1038/77083; PMID: 10888881
   PubMed Web of Science ®Google Scholar
• Morrissey C, Martinez A, Zatyka M, Agathanggelou A, Honorio S, Astuti D, et al. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma. Cancer Res 2001; 61:7277 - 81; PMID: 11585766
   PubMed Web of Science ®Google Scholar
• Morris MR, Gentle D, Abdulrahman M, Maina EN, Gupta K, Banks RE, et al. Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma. Cancer Res 2005; 65:4598 - 606; http://dx.doi.org/10.1158/0008-5472.CAN-04-3371; PMID: 15930277
   PubMed Web of Science ®Google Scholar
• Morris MR, Maher ER. Epigenetics of renal cell carcinoma: the path towards new diagnostics and therapeutics. Genome Med 2010; 2:59; http://dx.doi.org/10.1186/gm180; PMID: 20815920
   PubMedGoogle Scholar
• Morris MR, Ricketts CJ, Gentle D, McRonald F, Carli N, Khalili H, et al. Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma. Oncogene 2011; 30:1390 - 401; http://dx.doi.org/10.1038/onc.2010.525; PMID: 21132003
   PubMed Web of Science ®Google Scholar
• Ricketts CJ, Morris MR, Gentle D, Brown M, Wake N, Woodward ER, et al. Genome-wide CpG island methylation analysis implicates novel genes in the pathogenesis of renal cell carcinoma. Epigenetics 2012; 7:278 - 90; http://dx.doi.org/10.4161/epi.7.3.19103; PMID: 22430804
   PubMed Web of Science ®Google Scholar
• Sandoval J, Heyn H, Moran S, Serra-Musach J, Pujana MA, Bibikova M, et al. Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome. Epigenetics 2011; 6:692 - 702; http://dx.doi.org/10.4161/epi.6.6.16196; PMID: 21593595
   PubMed Web of Science ®Google Scholar
• Yusenko MV, Kuiper RP, Boethe T, Ljungberg B, van Kessel AG, Kovacs G. High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas. BMC Cancer 2009; 9:152; http://dx.doi.org/10.1186/1471-2407-9-152; PMID: 19445733
   PubMed Web of Science ®Google Scholar
• Tan MH, Wong CF, Tan HL, Yang XJ, Ditlev J, Matsuda D, et al. Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma. BMC Cancer 2010; 10:196; http://dx.doi.org/10.1186/1471-2407-10-196; PMID: 20462447
   PubMed Web of Science ®Google Scholar
• Petillo D, Kort EJ, Anema J, Furge KA, Yang XJ, Teh BT. MicroRNA profiling of human kidney cancer subtypes. Int J Oncol 2009; 35:109 - 14; http://dx.doi.org/10.3892/ijo_00000318; PMID: 19513557
   PubMed Web of Science ®Google Scholar
• Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 2009; 41:178 - 86; http://dx.doi.org/10.1038/ng.298; PMID: 19151715
   PubMed Web of Science ®Google Scholar
• McRonald FE, Morris MR, Gentle D, Winchester L, Baban D, Ragoussis J, et al. CpG methylation profiling in VHL related and VHL unrelated renal cell carcinoma. Mol Cancer 2009; 8:31; http://dx.doi.org/10.1186/1476-4598-8-31; PMID: 19493342
   PubMed Web of Science ®Google Scholar
• Lind GE, Raiborg C, Danielsen SA, Rognum TO, Thiis-Evensen E, Hoff G, et al. SPG20, a novel biomarker for early detection of colorectal cancer, encodes a regulator of cytokinesis. Oncogene 2011; 30:3967 - 78; http://dx.doi.org/10.1038/onc.2011.109; PMID: 21499309
   PubMed Web of Science ®Google Scholar
• Habbig S, Bartram MP, Müller RU, Schwarz R, Andriopoulos N, Chen S, et al. NPHP4, a cilia-associated protein, negatively regulates the Hippo pathway. J Cell Biol 2011; 193:633 - 42; http://dx.doi.org/10.1083/jcb.201009069; PMID: 21555462
   PubMed Web of Science ®Google Scholar
• Sun M, Lughezzani G, Perrotte P, Karakiewicz PI. Treatment of metastatic renal cell carcinoma. Nat Rev Urol 2010; 7:327 - 38; http://dx.doi.org/10.1038/nrurol.2010.57; PMID: 20458330
   PubMed Web of Science ®Google Scholar
• Du P, Kibbe WA, Lin SM. lumi: a pipeline for processing Illumina microarray. Bioinformatics 2008; 24:1547 - 8; http://dx.doi.org/10.1093/bioinformatics/btn224; PMID: 18467348
   PubMed Web of Science ®Google Scholar